Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 426

1.

Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.

Moore SG, Shenoy PJ, Fanucchi L, Tumeh JW, Flowers CR.

BMC Health Serv Res. 2009 Jan 13;9:9. doi: 10.1186/1472-6963-9-9.

2.

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.

Pataky R, Armstrong L, Chia S, Coldman AJ, Kim-Sing C, McGillivray B, Scott J, Wilson CM, Peacock S.

BMC Cancer. 2013 Jul 10;13:339. doi: 10.1186/1471-2407-13-339.

3.

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Schousboe JT, Kerlikowske K, Loh A, Cummings SR.

Ann Intern Med. 2011 Jul 5;155(1):10-20. doi: 10.7326/0003-4819-155-1-201107050-00003.

4.

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.

Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS.

Radiology. 2010 Mar;254(3):793-800. doi: 10.1148/radiol.09091086.

5.

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.

Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM.

JAMA. 2006 May 24;295(20):2374-84.

PMID:
16720823
6.

Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.

Pataky R, Ismail Z, Coldman AJ, Elwood M, Gelmon K, Hedden L, Hislop G, Kan L, McCoy B, Olivotto IA, Peacock S.

J Med Screen. 2014 Dec;21(4):180-8. doi: 10.1177/0969141314549758. Epub 2014 Sep 3.

PMID:
25186116
7.

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.

Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS.

Cancer. 2013 Mar 15;119(6):1266-76. doi: 10.1002/cncr.27864. Epub 2012 Nov 26.

8.

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.

Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Potterton J, Thompson D, Turnbull LW, Walker LG, Warren R, Leach MO; UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group.

Br J Cancer. 2006 Oct 9;95(7):801-10.

9.

Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.

Taneja C, Edelsberg J, Weycker D, Guo A, Oster G, Weinreb J.

J Am Coll Radiol. 2009 Mar;6(3):171-9. doi: 10.1016/j.jacr.2008.10.003.

PMID:
19248993
10.

Retrospective cost-effectiveness analysis of screening mammography.

Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG.

J Natl Cancer Inst. 2006 Jun 7;98(11):774-82.

11.

Cost effectiveness of mammography screening for Chinese women.

Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM.

Cancer. 2007 Aug 15;110(4):885-95. Erratum in: Cancer. 2010 Jan 15;116(2):540.

12.

Cost effectiveness of the NHS breast screening programme: life table model.

Pharoah PD, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N.

BMJ. 2013 May 9;346:f2618. doi: 10.1136/bmj.f2618. Erratum in: BMJ. 2013;346:f3822.

13.

Cost-effectiveness of breast cancer screening in women on dialysis.

Wong G, Howard K, Chapman JR, Craig JC.

Am J Kidney Dis. 2008 Nov;52(5):916-29. doi: 10.1053/j.ajkd.2008.06.015. Epub 2008 Sep 11.

PMID:
18789566
14.

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.

Saadatmand S, Tilanus-Linthorst MM, Rutgers EJ, Hoogerbrugge N, Oosterwijk JC, Tollenaar RA, Hooning M, Loo CE, Obdeijn IM, Heijnsdijk EA, de Koning HJ.

J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203. Epub 2013 Aug 12.

15.

Cost-effectiveness of digital mammography breast cancer screening.

Tosteson AN, Stout NK, Fryback DG, Acharyya S, Herman BA, Hannah LG, Pisano ED; DMIST Investigators.

Ann Intern Med. 2008 Jan 1;148(1):1-10.

16.

Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.

Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN.

Ann Intern Med. 2015 Feb 3;162(3):157-66. doi: 10.7326/M14-0692.

17.

[Cost-effectiveness of an organized breast cancer screening program in Southern Brazil].

Ribeiro RA, Caleffi M, Polanczyk CA.

Cad Saude Publica. 2013 Nov;29 Suppl 1:S131-45. Portuguese.

18.

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.

Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I.

J Natl Cancer Inst. 2014 Nov 30;107(1):380. doi: 10.1093/jnci/dju380. Print 2015 Jan.

19.

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.

Robertson C, Arcot Ragupathy SK, Boachie C, Dixon JM, Fraser C, Hernández R, Heys S, Jack W, Kerr GR, Lawrence G, MacLennan G, Maxwell A, McGregor J, Mowatt G, Pinder S, Ternent L, Thomas RE, Vale L, Wilson R, Zhu S, Gilbert FJ.

Health Technol Assess. 2011 Sep;15(34):v-vi, 1-322. doi: 10.3310/hta15340. Review.

20.

Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.

Feig S.

Obstet Gynecol Clin North Am. 2011 Mar;38(1):179-96, ix. doi: 10.1016/j.ogc.2011.02.009.

PMID:
21419333
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk